TLR7/8 agonist 3 is a highly potent TLR7 and TLR8 agonist, extracted from patent WO2016057618 (compound of formula (II)). References: [1]. Martha A. MILLER, et al. Vaccine compositions and methods of use to treat neonatal subjects.

纯度：≥98%

CAS：642473-95-8